Shenzhen, China

Lingyu He


 

Average Co-Inventor Count = 8.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Lingyu He in Nucleic Acid Technology

Introduction

Lingyu He is a prominent inventor based in Shenzhen, China, known for his significant contributions to the field of nucleic acid technology. With a total of four patents to his name, He has developed innovative methods and elements that enhance the efficiency of sequencing libraries and cyclic library constructions.

Latest Patents

One of Lingyu He's latest patents is titled "Linker element and method of using same to construct sequencing library." This invention provides a linker element consisting of linker A and linker B, which facilitates the construction of a sequencing library. The linker A is formed through the complementary pairing of a long nucleic acid strand and a short nucleic acid strand, ensuring linking directionality while addressing issues such as fragment interlinking and low linking efficiency. The second patent, "Method for constructing nucleic acid single-stranded cyclic library and reagents thereof," describes a method that combines transposase interruption with a restricted nick translation reaction, allowing for a simple and rapid construction of nucleic acid single-stranded cyclic libraries.

Career Highlights

Lingyu He has worked with notable companies in the biotechnology sector, including MGI Tech Co., Ltd. and BGI-Shenzhen Co., Limited. His experience in these organizations has contributed to his expertise in nucleic acid technologies and innovations.

Collaborations

Lingyu He has collaborated with several professionals in his field, including Chunyu Geng and Wenwei Zhang, who have contributed to his research and development efforts.

Conclusion

Lingyu He's innovative work in nucleic acid technology has led to significant advancements in sequencing and library construction methods. His patents reflect a commitment to improving efficiency and reducing costs in the biotechnology industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…